Acetyl-L-Carnitine

(ALCAR)

Studied for: Fibromyalgia

Fibromyalgia

What the research found

In fibromyalgia syndrome, ALCAR also reduces chronic pain scores and tender points. A clinical study achieved significant improvements in VAS pain and fibromyalgia impact scores. Significantly reduces pain and functional impairment. Preliminary efficacy across targeted trials.

Dose used in studies

1,500–3,000 mg/day

Side effects reported

well tolerated

References

Lowry2020, Kahraman2025, Schweiger2025

Not medical advice

Trials are run on specific people, for specific reasons, over a set period. Your medications, conditions and bloodwork can change what is safe for you. Ask a doctor or pharmacist before starting.